α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling
Authors
Keywords
ST6Gal-I, Immune escape, T cell, HCC, CD147
Journal
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-11
DOI
10.1007/s13105-019-00674-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells
- (2016) Maurizio Perdicchio et al. Oncotarget
- Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells
- (2014) Helge Bruns et al. AMINO ACIDS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- β-Galactoside α2,6-Sialyltranferase 1 Promotes Transforming Growth Factor-β-mediated Epithelial-Mesenchymal Transition
- (2014) Jishun Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
- (2013) J K Lee et al. BRITISH JOURNAL OF CANCER
- ST6Gal-I Protein Expression Is Upregulated in Human Epithelial Tumors and Correlates with Stem Cell Markers in Normal Tissues and Colon Cancer Cell Lines
- (2013) A. F. Swindall et al. CANCER RESEARCH
- ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
- (2013) Matthew J Schultz et al. Journal of Ovarian Research
- Caveolin-1 up-regulates ST6Gal-I to promote the adhesive capability of mouse hepatocarcinoma cells to fibronectin via FAK-mediated adhesion signaling
- (2012) Shengjin Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of the metastatic cell phenotype by sialylated glycans
- (2012) Matthew J. Schultz et al. CANCER AND METASTASIS REVIEWS
- Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Shibo Lin et al. Liver Cancer
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma
- (2011) Eishiro Mizukoshi et al. HEPATOLOGY
- Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells
- (2011) Amanda F. Swindall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor Evasion from T Cell Surveillance
- (2011) Katrin Töpfer et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Inflammation and immune surveillance in cancer
- (2011) Melvyn T. Chow et al. SEMINARS IN CANCER BIOLOGY
- Molecular Targeted Therapy of Biliary Tract Cancer – Results of the First Clinical Studies
- (2010) Marcus W. Wiedmann et al. CURRENT DRUG TARGETS
- Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation
- (2009) Kelly M Kennedy et al. Future Oncology
- Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy
- (2008) Melanie B. Thomas et al. ANNALS OF SURGICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now